単一光子放射断層撮影の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

単一光子放射断層撮影市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、単一光子放射断層撮影の世界市場規模は、2024年から2030年にかけてCAGR 2.78％を記録し、2030年には45億4,000万米ドルに達すると予測されています。

同市場はいくつかの主要要因によって牽引されています。主な市場促進要因の1つは、がんの有病率の増加です。がん、心血管疾患、神経疾患などの慢性疾患の有病率の増加は、単光子放出コンピュータ断層撮影（SPECT）市場の重要な促進要因です。

人口の高齢化に伴い、これらの疾患の罹患率が上昇し、SPECT画像診断のような正確な診断ツールに対する需要が高まっています。この動向により、疾患の進行や治療効果に関する詳細な洞察を提供できる高度な画像技術の導入が必要となり、同地域のSPECT市場を後押ししています。

ヘルスケア施設に対する資金援助や先進画像技術へのアクセスを改善するイニシアチブを通じた政府の支援は、市場の成長をさらに後押ししています。さらに、SPECTとCT（SPECT/CT）などの他の画像診断モダリティとの統合は診断精度を高め、さまざまな医療分野での応用を拡大しています。メーカーとヘルスケアプロバイダーはSPECT技術を進歩させ、臨床での使用を拡大するために積極的に協力しています。

Cardinal Health、GEヘルスケア、Siemens Healthineersなど市場の主要企業はSPECTシステムの革新と最適化のための研究開発に投資しています。これらの企業はまた、臨床試験やSPECTイメージングに不可欠な新しい放射性医薬品の導入を促進するため、病院や研究機関とパートナーシップを結んでいます。メーカーとヘルスケア施設が協力することで、最新技術を臨床医が容易に利用できるようになり、患者の転帰が改善されます。

新製品の発売と最先端技術の統合がSPECT市場の主要動向です。最近の動向には、SPECTスキャンの感度と特異性を高める高解像度イメージング・システムや新規放射性医薬品の開発が含まれます。例えば、最先端スキャナーのイントロダクションは、より良い診断と治療計画のための強化されたツールを臨床医に提供することで、QEII健康科学センターの核医学サービスに変革をもたらすと期待されています。これは、革新的なテクノロジーの導入を通じて質の高いヘルスケアを提供するという同センターのコミットメントに沿ったものです。このようなスキャナーの設置は、患者の予後改善を目的とした医療インフラへの重要な投資となります。

さらに、SPECT/CTのようなハイブリッド・イメージング・システムの病院環境への導入は、正確な診断と治療計画に不可欠な包括的な解剖学的・機能的イメージングを提供することで、この分野に革命をもたらしました。例えば、2024年5月、マーシー・サリバン病院はハイテクSPECT/CTイメージング・システムを導入し、診断能力を強化しました。高度なSPECTとCT技術を統合したこの新システムは、さまざまな病状に対して詳細で正確な画像診断を行うために設計されました。

この設置は病院にとって重要なアップグレードであり、より効果的に病気を診断・監視する能力を向上させるものです。新しいSPECT/CTシステムは、より高解像度の画像とより正確な診断情報を提供することで、より良い患者ケアをサポートすることを目的としています。これらの技術革新は、診断能力を向上させるだけでなく、ヘルスケア専門家間の学際的な協力関係を促進し、より効果的な患者管理戦略につながります。

同市場の主要プレーヤーには、GEヘルスケア、シーメンス・ヘルティニアーズ、Koninklijke Philips N.V.、Spectrum Dynamics Medical、Digirad Corporation、MILabs B.V.、Mediso Medical Imaging Systems、MiE GmbHなどがあります。主要企業は、世界な顧客に対応するため、製品発売などの戦略的な取り組みを行っています。2022年10月、スペクトラム・ダイナミクスはVERITON-CT-400シリーズデジタルSPECT/CTスキャナーの発売により、デジタル核医学イメージングにおける進歩を発表しました。これらの新しいスキャナーは固体検出器技術を利用し、ワイドボア構成を特徴としており、高エネルギーアイソトープをより高い精度と能力で画像化することを可能にしています。

単一光子放射断層撮影市場レポートハイライト：

• 製品別では、ハイブリッドSPECTシステムが2023年に67.12%の最大売上シェアを占めました。これらのハイブリッドシステムは、SPECTの機能イメージング機能とCTまたはMRIが提供する解剖学的詳細とを統合し、診断精度と治療計画を高める包括的なビューを提供します。ハイブリッドSPECTシステムは、腫瘍学、循環器学、神経学などさまざまな医療用途で使用され、身体の生理学的・解剖学的側面に関する詳細な洞察を提供します。
• 用途別では、腫瘍学が市場を独占し、2023年には49.58%の最大シェアを占めました。世界のがん罹患率の上昇が核医学イメージング市場、特にPETとSPECT技術の成長を牽引しています。これらの先進モダリティは、がんの分子特性を可視化する比類のない能力により広く採用され、疾患のより深い理解をもたらしています。
• 最終用途別では、病院分野が2023年に46.9%の最大市場シェアを占めています。これは、がんやCVDの早期発見を可能にし、迅速な介入と治療を可能にする病院における高度なイメージング技術に起因します。加えて、臨床ニーズを満たすための病院と他社との提携・協力関係も市場成長に寄与しています。
• 北米は、確立されたヘルスケア部門、イノベーションへのコミットメント、高度なインフラ、R&Dの重視、がんや慢性疾患の高い有病率、革新的技術の急速な導入などの要因により、世界市場を独占しています。
• アジア太平洋地域は、2024年から2030年までの予測期間においてCAGR 3.51%で最も速い成長が見込まれています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 単一光子放射断層撮影（SPECT）市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 単一光子放射断層撮影（SPECT）市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 単一光子放射断層撮影（SPECT）市場：製品別推定・動向分析

• セグメントダッシュボード
• 世界の単一光子放射断層撮影市場：製品変動分析
• 世界の単一光子放射断層撮影市場規模と動向分析、2018年～2030年
• スタンドアロンSPECTシステム
• ハイブリッドSPECTシステム

第5章 単一光子放射断層撮影（SPECT）市場：用途別推定・動向分析

• セグメントダッシュボード
• 世界の単一光子放射断層撮影市場：用途変動分析
• 世界の単一光子放射断層撮影市場規模と動向分析、2018年～2030年
• 2018年から2030年までの市場規模と予測および動向分析
• 心臓病学
  • 市場推計・予測2018～2030年
• 腫瘍学
  • 市場推計・予測2018～2030年
• 神経学
  • 市場推計・予測2018～2030年
• その他のアプリケーション
  • 市場推計・予測2018～2030年

第6章 単一光子放射断層撮影（SPECT）市場：最終用途別推定・動向分析

• セグメントダッシュボード
• 世界の単一光子放射断層撮影市場：最終用途変動分析
• 世界の単一光子放射断層撮影市場規模と動向分析、2018年～2030年
• 病院
• 画像診断センター
• その他

第7章 単一光子放射断層撮影（SPECT）市場：製品、用途、最終用途別の地域推定・動向分析

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界地域市場スナップショット
• 市場規模、予測動向分析、2018年から2030年：
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• 主要企業の市場シェア分析、2023年
• 企業のポジション分析
• 企業分類（新興企業、イノベーター、リーダー）
• 企業プロファイル
  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips NV
  • Spectrum Dynamics Medical
  • Digirad Corporation
  • MILabs BV
  • Mediso Medical Imaging Systems
  • MiE GmbH

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 4 Global single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 5 Global single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 6 North America single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 7 North America single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 8 North America single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 9 North America single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
• Table 10 U.S. single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 11 U.S. single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 12 U.S. single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 13 Canada single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 14 Canada single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 15 Canada single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 16 Mexico single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 17 Mexico single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 18 Mexico single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 19 Europe single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 20 Europe single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 21 Europe single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 22 Europe single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
• Table 23 UK single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 24 UK single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 25 UK single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 26 Germany single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 27 Germany single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 28 Germany single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 29 France single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 30 France single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 31 France single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 32 Italy single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 33 Italy single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 34 Italy single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 35 Spain single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 36 Spain single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 37 Spain single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 38 Denmark single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 39 Denmark single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 40 Denmark single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 41 Sweden single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 42 Sweden single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 43 Sweden single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 44 Norway single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 45 Norway single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 46 Norway single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
• Table 51 China single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 52 China single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 53 China single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 54 Japan single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 55 Japan single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 56 Japan single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 57 India single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 58 India single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 59 India single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 60 Australia single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 61 Australia single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 62 Australia single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 63 Thailand single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 64 Thailand single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 65 Thailand single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 66 South Korea single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 67 South Korea single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 68 South Korea single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 69 Latin America single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 70 Latin America single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 71 Latin America single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 72 Latin America single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
• Table 73 Brazil single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 74 Brazil single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 75 Brazil single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 76 Argentina single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 77 Argentina single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 78 Argentina single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
• Table 83 South Africa single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 84 South Africa single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 85 South Africa single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 89 UAE single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 90 UAE single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 91 UAE single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
• Table 92 Kuwait single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
• Table 93 Kuwait single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
• Table 94 Kuwait single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Market summary, 2023 (USD Million)
• Fig. 9 Market segmentation & scope
• Fig. 10 Market driver impact
• Fig. 11 Market restraint impact
• Fig. 12 Porter's analysis
• Fig. 13 SWOT analysis
• Fig. 14 Single-photon emission computed tomography (SPECT) market: Product outlook and key takeaways
• Fig. 15 Single-photon emission computed tomography (SPECT) market: Product movement analysis
• Fig. 16 Stand-alone SPECT Systems market, 2018 - 2030 (USD Million)
• Fig. 17 Hybrid SPECT Systems market, 2018 - 2030 (USD Million)
• Fig. 18 Single-photon emission computed tomography (SPECT) market: Application outlook and key takeaways
• Fig. 19 Single-photon emission computed tomography (SPECT) market: Application movement analysis
• Fig. 20 Cardiology market, 2018 - 2030 (USD Million)
• Fig. 21 Oncology market, 2018 - 2030 (USD Million)
• Fig. 22 Neurology market, 2018 - 2030 (USD Million)
• Fig. 23 Other Application market, 2018 - 2030 (USD Million)
• Fig. 24 Single-photon emission computed tomography (SPECT) market: End Use outlook and key takeaways
• Fig. 25 Single-photon emission computed tomography (SPECT) market: End Use movement analysis
• Fig. 26 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 27 Diagnostics imaging centers market, 2018 - 2030 (USD Million)
• Fig. 28 Research & Development Institutes market, 2018 - 2030 (USD Million)
• Fig. 29 Neurology imaging centers market, 2018 - 2030 (USD Million)
• Fig. 30 Other end users market, 2018 - 2030 (USD Million)
• Fig. 31 Single-photon emission computed tomography (SPECT) market: Regional movement analysis
• Fig. 32 Single-photon emission computed tomography (SPECT) market: Regional outlook and key takeaways
• Fig. 33 North America, by country
• Fig. 34 North America
• Fig. 35 North America market estimates and forecasts, 2018 - 2030
• Fig. 36 U.S.
• Fig. 37 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 38 Canada
• Fig. 39 Canada market estimates and forecasts, 2018 - 2030
• Fig. 40 Mexico
• Fig. 41 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 42 Europe
• Fig. 43 Europe market estimates and forecasts, 2018 - 2030
• Fig. 44 UK
• Fig. 45 UK market estimates and forecasts, 2018 - 2030
• Fig. 46 Germany
• Fig. 47 Germany market estimates and forecasts, 2018 - 2030
• Fig. 48 France
• Fig. 49 France market estimates and forecasts, 2018 - 2030
• Fig. 50 Italy
• Fig. 51 Italy market estimates and forecasts, 2018 - 2030
• Fig. 52 Spain
• Fig. 53 Spain market estimates and forecasts, 2018 - 2030
• Fig. 54 Denmark
• Fig. 55 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 56 Sweden
• Fig. 57 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 58 Norway
• Fig. 59 Norway market estimates and forecasts, 2018 - 2030
• Fig. 60 Asia Pacific
• Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 62 China
• Fig. 63 China market estimates and forecasts, 2018 - 2030
• Fig. 64 Japan
• Fig. 65 Japan market estimates and forecasts, 2018 - 2030
• Fig. 66 India
• Fig. 67 India market estimates and forecasts, 2018 - 2030
• Fig. 68 Thailand
• Fig. 69 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 70 South Korea
• Fig. 71 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 72 Australia
• Fig. 73 Australia market estimates and forecasts, 2018 - 2030
• Fig. 74 Latin America
• Fig. 75 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 76 Brazil
• Fig. 77 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 78 Argentina
• Fig. 79 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 80 Middle East and Africa
• Fig. 81 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 82 South Africa
• Fig. 83 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 84 Saudi Arabia
• Fig. 85 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 86 UAE
• Fig. 87 UAE market estimates and forecasts, 2018 - 2030
• Fig. 88 Kuwait
• Fig. 89 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 90 Heat map analysis
• Fig. 91 Market participant categorization
• Fig. 92 Single-photon emission computed tomography (SPECT) market share analysis, 2022
• Fig. 93 Strategy framework

Single-photon Emission Computed Tomography Market Growth & Trends:

The global single-photon emission computed tomography market size is expected to reach USD 4.54 billion by 2030, registering a CAGR of 2.78% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several key factors. One of the primary market drivers is the increasing prevalence of cancer. The increasing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions is a significant driver of the single-photon emission computed tomography (SPECT) market.

As the population ages, the incidence of these diseases rises, creating a greater demand for accurate diagnostic tools such as SPECT imaging. This trend necessitates the adoption of advanced imaging technologies that can provide detailed insights into disease progression and treatment efficacy, thereby boosting the SPECT market in the region.

Government support through funding for healthcare facilities and initiatives to improve access to advanced imaging technologies is further propelling market growth. In addition, the integration of SPECT with other imaging modalities, such as CT (SPECT/CT), enhances diagnostic accuracy and expands its applications in various medical fields.Manufacturers and healthcare providers are actively collaborating to advance SPECT technology and expand its use in clinical practice.

Major players in the market, such as Cardinal Health, GE Healthcare, and Siemens Healthineers, are investing in research and development to innovate and optimize SPECT systems. These companies are also forming partnerships with hospitals and research institutions to facilitate clinical trials and the introduction of new radiopharmaceuticals, which are essential for SPECT imaging. The collaboration between manufacturers and healthcare facilities ensures that the latest technologies are readily available to clinicians, thereby improving patient outcomes.

The launch of new products and the integration of cutting-edge technologies are key trends in the SPECT market. Recent advancements include the development of high-resolution imaging systems and novel radiopharmaceuticals that enhance the sensitivity and specificity of SPECT scans. For instance, the introduction of a cutting-edge scanner is expected to transform nuclear medicine services at QEII Health Sciences Centre by providing clinicians with enhanced tools for better diagnosis and treatment planning. This aligns with the center's commitment to delivering high-quality healthcare through the adoption of innovative technologies. Such scanner's installation represents a significant investment in healthcare infrastructure, aimed at improving patient outcomes.

Further, the introduction of hybrid imaging systems such as SPECT/CT in hospital settings has revolutionized the field by providing comprehensive anatomical and functional imaging, which is crucial for accurate diagnosis and treatment planning. For instance, in May 2024, Mercy Sullivan Hospital installed a high-tech SPECT/CT imaging system, enhancing its diagnostic capabilities. The new system, which integrates advanced SPECT and CT technologies, was designed to provide detailed and accurate imaging for a variety of medical conditions.

The installation marked a significant upgrade for the hospital, improving its ability to diagnose and monitor diseases more effectively. The new SPECT/CT system aims to support better patient care by offering higher resolution images and more precise diagnostic information.These innovations not only improve diagnostic capabilities but also foster greater interdisciplinary collaboration among healthcare professionals, leading to more effective patient management strategies.

Some of the key players in the market are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Spectrum Dynamics Medical, Digirad Corporation, MILabs B.V., Mediso Medical Imaging Systems, MiE GmbH. Key player are involved in undertaking strategic initiatives such as product launch to cater global clientele. In October 2022, Spectrum Dynamics announced its advancement in digital nuclear medicine imaging with the launch of the VERITON-CT-400 Series Digital SPECT/CT scanners. These new scanners utilize solid-state detector technology and feature a wide-bore configuration, enabling them to image high-energy isotopes with enhanced precision and capability.

Single-photon Emission Computed Tomography Market Report Highlights:

• Based on product, hybrid SPECT systems accounted for largest revenue share of 67.12% in 2023. These hybrid systems integrate SPECT's functional imaging capabilities with the anatomical detail provided by CT or MRI, offering a comprehensive view that enhances diagnostic accuracy and treatment planning. Hybrid SPECT systems are used in various medical applications, including oncology, cardiology, and neurology, to provide detailed insights into the physiological and anatomical aspects of the body
• Based on application, oncology dominated the market and accounted for the largest share of 49.58% in 2023. The rising global incidence of cancer is driving the growth of the nuclear imaging market, particularly in PET and SPECT technologies. These advanced modalities have gained widespread adoption due to their unparalleled ability to visualize the molecular characteristics of cancer, providing a deeper understanding of the disease
• Based on end use, hospitals segment is dominated the end use segments with the largest market share of 46.9% in 2023. This is attributable to advanced imaging technologies in hospitals that enable the early detection of cancer, CVD's, allowing for prompt intervention and treatment. In addition, partnerships & collaborations between hospitals and other companies to meet clinical needs contribute to market growth
• North America dominated the global market due to the attributed to the well-established healthcare sector, commitment to innovation, advanced infrastructure, a strong emphasis on R&D, the high prevalence of cancer and chronic diseases, and rapid adoption of innovative technologies
• Asia Pacific region is expected to witness fastest growth with a CAGR of 3.51% over the forecast period from 2024 to 2030, due to presence of manufacturers with innovative devices manufacturing capabilities coupled with accelerated diagnostic research capabilities

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Single-Photon Emission Computed Tomography (SPECT) Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of cancer
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Increasing awareness of diagnostic needs
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. lack of skilled professionals
• 3.3. Single-Photon Emission Computed Tomography (SPECT) Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Single-Photon Emission Computed Tomography (SPECT) Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Single-Photon Emission Computed Tomography (SPECT) Product Market Movement Analysis
• 4.3. Global Single-Photon Emission Computed Tomography (SPECT) Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Stand-alone SPECT Systems
  • 4.4.1. Stand-alone SPECT systems market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Hybrid SPECT Systems
  • 4.5.1. Hybrid SPECT systems market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Single-Photon Emission Computed Tomography (SPECT) Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Single-Photon Emission Computed Tomography (SPECT) Application Market Movement Analysis
• 5.3. Global Single-Photon Emission Computed Tomography (SPECT) Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Cardiology
  • 5.5.1. Cardiology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Oncology
  • 5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Neurology
  • 5.7.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Other Application
  • 5.8.1. Other application market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Single-Photon Emission Computed Tomography (SPECT) Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Single-Photon Emission Computed Tomography (SPECT) End Use Market Movement Analysis
• 6.3. Global Single-Photon Emission Computed Tomography (SPECT) Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Diagnostic Imaging Centers
  • 6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Single-Photon Emission Computed Tomography (SPECT) Market: Regional Estimates & Trend Analysis By Product, Application, End Use

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework/ reimbursement structure
    • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework/ reimbursement structure
    • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework/ reimbursement structure
    • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Regulatory framework/ reimbursement structure
  • 7.6.2. UK
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework/ reimbursement structure
    • 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework/ reimbursement structure
    • 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework/ reimbursement structure
    • 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework/ reimbursement structure
    • 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework/ reimbursement structure
    • 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework/ reimbursement structure
    • 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Competitive scenario
    • 7.6.8.3. Regulatory framework/ reimbursement structure
    • 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key country dynamics
    • 7.6.9.2. Competitive scenario
    • 7.6.9.3. Regulatory framework/ reimbursement structure
    • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Regulatory framework/ reimbursement structure
  • 7.7.2. Japan
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework/ reimbursement structure
    • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework/ reimbursement structure
    • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework/ reimbursement structure
    • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. Australia
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework/ reimbursement structure
    • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. South Korea
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework/ reimbursement structure
    • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key country dynamics
    • 7.7.7.2. Competitive scenario
    • 7.7.7.3. Regulatory framework/ reimbursement structure
    • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Regulatory framework/ reimbursement structure
  • 7.8.2. Brazil
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework/ reimbursement structure
    • 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework/ reimbursement structure
    • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. Regulatory framework/ reimbursement structure
  • 7.9.2. South Africa
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework/ reimbursement structure
    • 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework/ reimbursement structure
    • 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework/ reimbursement structure
    • 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key country dynamics
    • 7.9.5.2. Competitive scenario
    • 7.9.5.3. Regulatory framework/ reimbursement structure
    • 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key company market share analysis, 2023
• 8.4. Company Position Analysis
• 8.5. Company Categorization (Emerging Players, Innovators and Leaders
• 8.6. Company Profiles
  • 8.6.1. GE Healthcare
    • 8.6.1.1. Company overview
    • 8.6.1.2. Financial performance
    • 8.6.1.3. Application benchmarking
    • 8.6.1.4. Strategic initiatives
  • 8.6.2. Siemens Healthineers
    • 8.6.2.1. Company overview
    • 8.6.2.2. Financial performance
    • 8.6.2.3. Application benchmarking
    • 8.6.2.4. Strategic initiatives
  • 8.6.3. Koninklijke Philips N.V.
    • 8.6.3.1. Company overview
    • 8.6.3.2. Financial performance
    • 8.6.3.3. Application benchmarking
    • 8.6.3.4. Strategic initiatives
  • 8.6.4. Spectrum Dynamics Medical
    • 8.6.4.1. Company overview
    • 8.6.4.2. Financial performance
    • 8.6.4.3. Application benchmarking
    • 8.6.4.4. Strategic initiatives
  • 8.6.5. Digirad Corporation
    • 8.6.5.1. Company overview
    • 8.6.5.2. Financial performance
    • 8.6.5.3. Application benchmarking
    • 8.6.5.4. Strategic initiatives
  • 8.6.6. MILabs B.V.
    • 8.6.6.1. Company overview
    • 8.6.6.2. Financial performance
    • 8.6.6.3. Application benchmarking
    • 8.6.6.4. Strategic initiatives
  • 8.6.7. Mediso Medical Imaging Systems
    • 8.6.7.1. Company overview
    • 8.6.7.2. Financial performance
    • 8.6.7.3. Application benchmarking
    • 8.6.7.4. Strategic initiatives
  • 8.6.8. MiE GmbH
    • 8.6.8.1. Company overview
    • 8.6.8.2. Financial performance
    • 8.6.8.3. Application benchmarking
    • 8.6.8.4. Strategic initiatives